EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer

Siyuan Zuo, Yong Huang, Junwei Zou iD

IUBMB Life · 2024-12 · 76 (12) · 1050-1057

DOI: 10.1002/iub.2908 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift IUBMB Life, online erschienen am 12.08.2024. Verfasst von Siyuan Zuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colorectal Neoplasms, Immunotherapy, Probiotics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Key Project in Natural Science Research in Higher Education Institutions of Anhui Province, Key Project of Natural Science Foundation of Wannan Medical College, Key Research Project of Wuhu Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic literature review and meta‐analysis provide an overview of the critical role of gut microbiota in modulating the efficacy of immunotherapy for colorectal cancer. Gut microbes influence host immune responses through multiple mechanisms including modulation of immune cell activity, metabolite action, and immune tolerance. The ability of specific gut microbes to improve the efficacy of immune checkpoint inhibitors has been linked to their ability to improve gut barrier function, modulate immune cell activity, and produce key immunomodulatory metabolites such as short‐chain fatty acids. In addition, the composition and diversity of the gut microbiota are strongly associated with the efficacy of immunotherapies, demonstrating the potential to improve therapeutic response by modifying the gut microbiota. This paper also discusses the prospect of manipulating the gut microbiota through strategies such as fecal microbial transplantation, probiotic supplementation, and dietary modifications to optimize the efficacy of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColorectal NeoplasmsImmunotherapyProbioticsHumansFecal Microbiota TransplantationImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

colorectal cancergut microbiotaimmunotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.
  • School of Clinical Medicine, Wannan Medical College, Wuhu, Anhui, China.

ORCID-Profile: Junwei Zou

Förderung

  • Key Project in Natural Science Research in Higher Education Institutions of Anhui Province
  • Key Project of Natural Science Foundation of Wannan Medical College
  • Key Research Project of Wuhu Municipal Health Commission
  • Climbing Scientific Peak Project for Talents, the Second Affiliated Hospital of Wannan Medical College

Zitieren

APA

Zuo, S., Huang, Y., & Zou, J. (2024). The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer. IUBMB Life, 76(12), 1050-1057. https://doi.org/10.1002/iub.2908

Vancouver

Zuo S, Huang Y, Zou J. The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer. IUBMB Life. 2024;76(12):1050-1057. doi:10.1002/iub.2908

BibTeX
@article{Zuo2024,
  author = {Zuo, Siyuan and Huang, Yong and Zou, Junwei},
  title = {The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer},
  journal = {IUBMB Life},
  year = {2024},
  volume = {76},
  number = {12},
  pages = {1050--1057},
  doi = {10.1002/iub.2908}
}
Kostenlos starten →